Malta - engelsk - Medicines Authority

galenicum health, s.l. calle sant gabriel, 50 08950 esplugues de llobregat (barcelona) , spain - dabigatran etexilate - hard capsule - dabigatran etexilate 110 mg - antithrombotic agents

Malta - engelsk - Medicines Authority

galenicum health, s.l. calle sant gabriel, 50 08950 esplugues de llobregat (barcelona) , spain - dabigatran etexilate - hard capsule - dabigatran etexilate 150 mg - antithrombotic agents

Irland - engelsk - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - dabigatran etexilate mesilate - capsule, hard - dabigatran etexilate

Irland - engelsk - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - dabigatran etexilate mesilate - capsule, hard - dabigatran etexilate

Irland - engelsk - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - dabigatran etexilate mesilate - capsule, hard - dabigatran etexilate

Irland - engelsk - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - dabigatran etexilate mesilate - capsule, hard - dabigatran etexilate

Irland - engelsk - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - dabigatran etexilate mesilate - capsule, hard - dabigatran etexilate

Irland - engelsk - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - dabigatran etexilate mesilate - capsule, hard - dabigatran etexilate

Irland - engelsk - HPRA (Health Products Regulatory Authority)

eckert & ziegler radiopharma gmbh - germanium (68ge) chloride; gallium (68ga) chloride - radionuclide generator - 0.74-1.85 gigabecquerel(s) - other diagnostic radiopharmaceuticals

USA - engelsk - NLM (National Library of Medicine)

ucsf radiopharmaceutical facility - gallium ga-68 gozetotide (unii: zj0ekr6m10) (gallium ga-68 gozetotide - unii:zj0ekr6m10) - gallium ga 68 gozeotide injection is indicated for positron emission tomography (pet) of prostate-specific membrane antigen (psma) positive lesions in men with prostate cancer: - with suspected metastasis who are candidates for initial definitive therapy. - with suspected recurrence based on elevated serum prostate-specific antigen (psa) level. none risk summary gallium ga 68 gozetotide injection is not indicated for use in females. there are no available data with gallium ga 68 gozetotide injection use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. all radiopharmaceuticals, including gallium ga 68 gozetotide injection, have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose. animal reproduction studies have not been conducted with gallium ga 68 gozetotide injection. risk summary gallium ga 68 gozetotide injection is not indicated for use in females. there ar